LC
UTHR icon

Lindbrook Capital’s United Therapeutics UTHR Stock Holding History

Lindbrook Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$64.1K Buy
208
+111
+114% +$38K 0.01% 887
2024
Q4 		$34.2K Buy
97
+6
+7% +$2.21K ﹤0.01% 983
2024
Q3 		$32.6K Buy
91
+11
+14% +$3.72K ﹤0.01% 1019
2024
Q2 		$25.5K Buy
80
+26
+48% +$6.88K ﹤0.01% 1110
2024
Q1 		$12.4K Sell
54
-48
-47% -$10.8K ﹤0.01% 1455
2023
Q4 		$22.4K Buy
102
+61
+149% +$14.1K ﹤0.01% 1122
2023
Q3 		$9.26K Buy
41
+3
+8% +$691 ﹤0.01% 1456
2023
Q2 		$8.39K Sell
38
-21
-36% -$4.65K ﹤0.01% 1575
2023
Q1 		$13.2K Buy
59
+11
+23% +$2.71K ﹤0.01% 1280
2022
Q4 		$13.3K Buy
48
+19
+66% +$4.8K ﹤0.01% 1286
2022
Q3 		$6K Buy
29
+4
+16% +$894 ﹤0.01% 1607
2022
Q2 		$6K Buy
25
+10
+67% +$2.03K ﹤0.01% 1500
2022
Q1 		$3K Buy
15
+2
+15% +$381 ﹤0.01% 1888
2021
Q4 		$3K Sell
13
-6
-32% -$1.18K ﹤0.01% 1708
2021
Q3 		$4K Buy
19
+3
+19% +$591 ﹤0.01% 1354
2021
Q2 		$3K Hold
16
– – ﹤0.01% 1518
2021
Q1 		$3K Buy
16
+11
+220% +$1.83K ﹤0.01% 1475
2020
Q4 		$1K Hold
5
– – ﹤0.01% 1708
2020
Q3 		$1K Buy
+5
New +$549 ﹤0.01% 1669
2019
Q3 		– Sell
-40
Closed -$3K – 1542
2019
Q2 		$3K Hold
40
– – ﹤0.01% 1175
2019
Q1 		$4K Hold
40
– – ﹤0.01% 1139
2018
Q4 		$4K Buy
+40
New +$4.64K ﹤0.01% 1086

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lindbrook Capital's UTHR Position: Q1 2025 in Review

Lindbrook Capital increased its United Therapeutics (UTHR) stake by 114% in Q1 2025, buying an estimated $38K and bringing the position to 208 shares worth $64.1K. The position accounts for 0.01% of the portfolio, ranked #887.

Lindbrook Capital first reported a position in UTHR in Q4 2018 and has held it in 22 quarters since. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Lindbrook Capital held 208 shares of United Therapeutics worth $64.1K as of Q1 2025.
  • Lindbrook Capital bought 111 United Therapeutics shares in Q1 2025, an estimated $38K.
  • United Therapeutics made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #887 holding.
  • Lindbrook Capital first reported a position in United Therapeutics in Q4 2018 and has held it in 22 quarters since.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.